GO:0006532 L-aspartate biosynthetic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006532 describes the chemical reactions and pathways that produce L-aspartate, the anion of aspartic acid.
• L-aspartate is a non-essential amino acid that serves as a precursor for proteins, nucleotides, and the malate-aspartate shuttle.
• Key enzymes include aspartate dehydrogenase, aspartase, and aspartate aminotransferase, which catalyze reductive amination or transamination.
• Dysregulation of aspartate biosynthesis is linked to metabolic disorders, obesity, and neurological conditions.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of aspartate biosynthetic genes.
• Understanding this pathway supports metabolic engineering and therapeutic development for diseases such as ME/CFS and long COVID.
Description
L-aspartate biosynthetic process (GO:0006532) is a fundamental metabolic pathway that generates the amino acid L-aspartate, a key building block for proteins and a central metabolite in cellular energy metabolism. This process is essential for nitrogen balance, nucleotide synthesis, and the malate-aspartate shuttle, which transfers reducing equivalents across the mitochondrial membrane. Researchers study this pathway to understand how cells maintain aspartate homeostasis and how its disruption contributes to disease. Recent advances in CRISPR gene editing have made it possible to systematically interrogate the genes involved in aspartate biosynthesis, from knockout to precise point mutations. This article provides a comprehensive overview of the pathway, its genetic components, disease relevance, and state-of-the-art research methods.
L-aspartate biosynthetic process At A Glance
| GO ID | GO:0006532 |
|---|---|
| GO term | L-aspartate biosynthetic process |
| Ontology | biological_process |
| Synonym | aspartate anabolism, aspartate biosynthesis, aspartate formation, aspartate synthesis |
| Major function | Production of L-aspartate for protein synthesis, nucleotide metabolism, and energy shuttling |
| Key enzymes | L-aspartate dehydrogenase, aspartase, aspartate aminotransferase |
| Pathway location | Cytosol and mitochondria |
| Related diseases | Obesity, ME/CFS, long COVID, neurological disorders |
What Is GO:0006532?
According to the Gene Ontology, GO:0006532 L-aspartate biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of aspartate, the anion derived from aspartic acid, 2-aminobutanedioic acid. This biological process encompasses all enzymatic steps that convert precursor molecules into L-aspartate, including reductive amination of oxaloacetate and transamination reactions.
Why Is L-aspartate biosynthetic process Important in Cell Biology?
L-aspartate biosynthesis is critical for maintaining cellular nitrogen balance, supporting the malate-aspartate shuttle, and providing precursors for nucleotides and other amino acids. Dysregulation of this pathway has been implicated in metabolic disorders such as obesity and in complex diseases like ME/CFS and long COVID, where shared metabolic dysregulation has been observed. Therefore, understanding the enzymes and regulatory mechanisms of L-aspartate biosynthesis offers potential therapeutic targets and biotechnological applications.
• Provides L-aspartate for protein synthesis and as a precursor for asparagine, arginine, and nucleotides.
• Supports the malate-aspartate shuttle, which is essential for mitochondrial energy metabolism.
• Plays a role in nitrogen detoxification and ammonia assimilation.
• Its dysregulation is linked to diet-induced obesity and metabolic syndrome.
• Alterations in aspartate metabolism are observed in ME/CFS and long COVID.
• Enzymes like L-aspartate dehydrogenase are used in industrial biocatalysis.
• Aspartase activation by L-aspartate suggests feedback regulation.
• The DcuA exchanger for L-aspartate uptake is important in bacterial metabolism.
• Aspartylation of sterols in fungi highlights diverse roles of aspartate.
• CRISPR screening can identify novel genes in the pathway for therapeutic targeting.
What Happens During L-aspartate biosynthetic process?
Reductive Amination of Oxaloacetate
In simple terms: A precursor molecule is converted into aspartate by adding an amino group.
The primary route for L-aspartate biosynthesis is the reductive amination of oxaloacetate, catalyzed by L-aspartate dehydrogenase or aspartate aminotransferase. This reaction uses NADH or NADPH as a cofactor and releases water. In bacteria, aspartase can also catalyze the reversible deamination of aspartate to fumarate and ammonia, but under physiological conditions it contributes to aspartate synthesis.
Transamination Reactions
In simple terms: Amino groups are transferred from other amino acids to oxaloacetate to make aspartate.
Aspartate aminotransferase (AST) catalyzes the transfer of an amino group from glutamate to oxaloacetate, yielding alpha-ketoglutarate and L-aspartate. This reaction is reversible and is central to the malate-aspartate shuttle. The enzyme is pyridoxal phosphate-dependent and exists in cytosolic and mitochondrial isoforms.
Regulation by Substrate Availability
In simple terms: The pathway speeds up or slows down based on how much starting material is available.
L-aspartate biosynthesis is regulated by the availability of oxaloacetate, which is derived from the tricarboxylic acid cycle, and by the redox state of the cell. In bacteria, the DcuA exchanger facilitates uptake of L-aspartate and C4-dicarboxylates, influencing intracellular levels. Additionally, L-aspartate can activate aspartase, suggesting a feedback activation mechanism.
Integration with Energy Metabolism
In simple terms: Aspartate production is tied to how cells generate energy.
The malate-aspartate shuttle relies on aspartate biosynthesis to transfer electrons from cytosolic NADH to the mitochondrial electron transport chain. This shuttle is essential for maintaining glycolysis and oxidative phosphorylation. Consequently, aspartate biosynthesis is tightly linked to cellular energy status and is modulated by metabolic signals.
Key Genes Involved in GO:0006532 L-aspartate biosynthetic process
The following genes and proteins are central to L-aspartate biosynthetic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ASPDH | L-aspartate dehydrogenase, catalyzes reductive amination of oxaloacetate | Target for metabolic engineering and structural studies |
| aspA | Aspartase, catalyzes reversible deamination of aspartate | Model enzyme for feedback regulation |
| GOT1 | Cytosolic aspartate aminotransferase, transamination | Key for malate-aspartate shuttle |
| GOT2 | Mitochondrial aspartate aminotransferase, transamination | Essential for energy metabolism |
| DcuA | L-aspartate/C4-dicarboxylate exchanger | Bacterial uptake and metabolism |
| ASD | Aspartate beta-semialdehyde dehydrogenase | Aspartate pathway to lysine, threonine, methionine |
| AspC | Aspartate aminotransferase | Model for substrate specificity |
| PanD | L-aspartate-alpha-decarboxylase | Beta-alanine production |
| PyrB | Aspartate transcarbamoylase | Nucleotide biosynthesis |
| ArgG | Argininosuccinate synthase | Arginine biosynthesis |
| AsnB | Asparagine synthetase | Asparagine biosynthesis |
| MDH1 | Malate dehydrogenase | Malate-aspartate shuttle |
| MDH2 | Mitochondrial malate dehydrogenase | Malate-aspartate shuttle |
| SLC25A12 | Mitochondrial aspartate-glutamate carrier | Shuttle component |
| SLC25A13 | Mitochondrial aspartate-glutamate carrier | Shuttle component |
| AspDH | L-aspartate dehydrogenase | Biocatalysis |
| AspAT | Aspartate aminotransferase | Clinical biomarker |
How Is L-aspartate biosynthetic process Regulated?
L-aspartate biosynthetic process is regulated at multiple levels. In bacteria, the DcuA exchanger controls aspartate uptake, while aspartase activity is modulated by substrate availability and feedback activation by L-aspartate. In mammalian cells, the pathway is influenced by the redox state and the demand for the malate-aspartate shuttle, which is regulated by the mitochondrial aspartate-glutamate carriers SLC25A12 and SLC25A13. Additionally, systemic metabolic dysregulation in conditions like ME/CFS and long COVID can alter aspartate biosynthesis, as revealed by systems modeling.
L-aspartate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GOT2 | Mitochondrial aspartate aminotransferase deficiency | Knockout mouse, patient-derived iPSCs |
| SLC25A12 | Global developmental delay, epilepsy | Knock-in mouse with point mutation |
| ASPDH | Metabolic disorders | CRISPR knockout in cell lines |
| PanD | Beta-alanine production | Overexpression in E. coli |
| DcuA | Bacterial metabolism | Knockout in Actinobacillus succinogenes |
Metabolic Disorders and Obesity
L-aspartate supplementation ameliorates diet-induced obesity by increasing adipocyte energy expenditure, suggesting that aspartate biosynthesis plays a role in energy balance. Dysregulation of aspartate metabolism may contribute to obesity and metabolic syndrome.
ME/CFS and Long COVID
Systems modeling has revealed shared metabolic dysregulation, including aspartate metabolism, in ME/CFS and long COVID, highlighting potential therapeutic targets.
Neurological and Mitochondrial Diseases
The malate-aspartate shuttle, which depends on aspartate biosynthesis, is critical for brain energy metabolism. Disruption of this shuttle can lead to neurological disorders.
From L-aspartate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ASPDH knockout on aspartate levels? | CRISPR knockout cell line |
| How does a point mutation in GOT2 affect enzyme activity? | CRISPR point mutation knock-in |
| Can overexpression of PanD increase beta-alanine production? | CRISPR overexpression in E. coli |
| What is the role of DcuA in aspartate uptake? | Knockout in A. succinogenes |
| Does L-aspartate supplementation affect obesity? | Mouse model with diet-induced obesity |
| How does aspartate biosynthesis regulate the malate-aspartate shuttle? | CRISPR knockout of SLC25A12 in human cells |
How to Study the L-aspartate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression levels | Identify upregulated genes in aspartate biosynthesis |
| CRISPR screening | Gene essentiality and function | Discover novel regulators of aspartate synthesis |
| Metabolomics | Metabolite concentrations | Quantify aspartate and related metabolites |
| Isotope tracing | Metabolic flux | Measure aspartate synthesis rate |
| Enzyme kinetics | Catalytic activity | Characterize mutant enzymes |
| Western blot | Protein expression | Validate knockout or overexpression |
| Immunofluorescence | Protein localization | Determine subcellular localization of enzymes |
Genomic and Transcriptomic Approaches
RNA-seq and CRISPR screening can identify genes involved in L-aspartate biosynthesis and their expression changes under different conditions.
Metabolomic and Flux Analysis
Mass spectrometry-based metabolomics and isotope tracing measure aspartate levels and flux through the pathway, revealing metabolic rewiring in disease.
Enzymatic Assays
In vitro enzymatic assays with purified enzymes such as L-aspartate dehydrogenase or aspartase determine kinetic parameters and regulatory mechanisms.
Structural Biology
X-ray crystallography and cryo-EM provide insights into the catalytic mechanism and substrate specificity of key enzymes.
How CRISPR Can Be Used to Study GO:0006532 L-aspartate biosynthetic process
Knockout
CRISPR knockout of genes such as ASPDH or GOT2 can abolish L-aspartate biosynthesis, leading to metabolic defects that can be rescued by exogenous aspartate. This approach helps establish gene essentiality.
Point Mutation
Introducing specific point mutations in catalytic residues of aspartate biosynthetic enzymes allows precise structure-function studies and modeling of human disease variants.
Knock-in
Knock-in of tagged versions of enzymes (e.g., GFP or FLAG) enables live-cell imaging and proteomic analysis of the pathway components.
Overexpression
CRISPR activation or cDNA overexpression can increase flux through the pathway, useful for metabolic engineering of beta-alanine or other products.
How EDITGENE Supports L-aspartate biosynthetic process Research
Researchers studying L-aspartate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for L-aspartate biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ASPA Knockout HEK293 Cell Line | EDJ-KQ4106 | Human | 443 | Details Get a Quote |
| GOT1 Knockout HEK293 Cell Line | EDJ-KQ4751 | Human | 2805 | Details Get a Quote |
| GOT1L1 Knockout HEK293 Cell Line | EDJ-KQ9389 | Human | 137362 | Details Get a Quote |
| GOT1 Knockout HCT 116 Cell Line | EDJ-KQ26273 | Human | 2805 | Details Get a Quote |
| GOT1 Knockout A-549 Cell Line | EDJ-KQ27508 | Human | 2805 | Details Get a Quote |
| GOT1 Knockout HeLa Cell Line | EDJ-KQ27510 | Human | 2805 | Details Get a Quote |
| ASPA Knockout HeLa Cell Line | EDJ-KQ52674 | Human | 443 | Details Get a Quote |
| GOT1L1 Knockout HeLa Cell Line | EDJ-KQ58372 | Human | 137362 | Details Get a Quote |
| ASPA Knockout A-549 Cell Line | EDJ-KQ61146 | Human | 443 | Details Get a Quote |
| GOT1L1 Knockout A-549 Cell Line | EDJ-KQ66860 | Human | 137362 | Details Get a Quote |
| ASPA Knockout HCT 116 Cell Line | EDJ-KQ69634 | Human | 443 | Details Get a Quote |
| GOT1L1 Knockout HCT 116 Cell Line | EDJ-KQ75263 | Human | 137362 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About L-aspartate biosynthetic process
What is L-aspartate biosynthetic process?
It is the biological process (GO:0006532) that produces L-aspartate, an amino acid, through enzymatic reactions such as reductive amination and transamination.
What genes are involved in L-aspartate biosynthetic process?
Key genes include ASPDH, GOT1, GOT2, aspA, and DcuA, which encode enzymes and transporters for aspartate synthesis and uptake.
Why is L-aspartate biosynthesis important?
It provides aspartate for protein synthesis, nucleotide metabolism, and the malate-aspartate shuttle, and its dysregulation is linked to obesity and ME/CFS.
How is L-aspartate biosynthetic process regulated?
It is regulated by substrate availability, redox state, and feedback mechanisms, including activation of aspartase by L-aspartate.
What diseases are associated with L-aspartate biosynthesis?
Diseases include diet-induced obesity, ME/CFS, long COVID, and neurological disorders related to mitochondrial dysfunction.
How can CRISPR be used to study L-aspartate biosynthesis?
CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of genes in the pathway.
What methods are used to study L-aspartate biosynthesis?
Methods include RNA-seq, metabolomics, isotope tracing, enzyme assays, and structural biology.
What is the role of aspartase in L-aspartate biosynthesis?
Aspartase catalyzes the reversible deamination of aspartate and can be activated by L-aspartate, contributing to aspartate homeostasis.
How does L-aspartate affect obesity?
L-aspartate supplementation ameliorates diet-induced obesity by increasing adipocyte energy expenditure.
What is the malate-aspartate shuttle?
It is a system that transfers reducing equivalents from cytosolic NADH into mitochondria, relying on aspartate biosynthesis and transamination.
Conclusion
L-aspartate biosynthetic process (GO:0006532) is a central metabolic pathway with far-reaching implications for cellular energy metabolism, nitrogen balance, and human disease. Understanding its genetic and biochemical regulation is essential for developing therapeutic strategies against metabolic and neurological disorders. EDITGENE offers advanced CRISPR tools to accelerate this research, from knockout to precise point mutations and library screening.
References
- 1. Li GH et al.. 2025. Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID.. Int J Mol Sci 26(13) PMID: 40649860
- 2. Li Y et al.. 2012. L-aspartate dehydrogenase: features and applications.. Appl Microbiol Biotechnol 93(2):503-16 PMID: 22120624
- 3. Das A et al.. 2020. L-Aspartate, L-Ornithine and L-Ornithine-L-Aspartate (LOLA) and Their Impact on Brain Energy Metabolism.. Neurochem Res 45(6):1438-1450 PMID: 32424601
- 4. Wang L et al.. 2020. Enhanced production of β-alanine through co-expressing two different subtypes of L-aspartate-α-decarboxylase.. J Ind Microbiol Biotechnol 47(6-7):465-474 PMID: 32524454
- 5. Guo SY et al.. 2025. L-aspartate ameliorates diet-induced obesity by increasing adipocyte energy expenditure.. Diabetes Obes Metab 27(2):606-618 PMID: 39529440
- 6. Ida N et al.. 1985. L-Aspartate-induced activation of aspartase.. J Biochem 98(1):35-9 PMID: 3900058
- 7. Cho YB et al.. 2023. Asuc_0142 of Actinobacillus succinogenes 130Z is the l-aspartate/C4-dicarboxylate exchanger DcuA.. Microbiology (Reading) 169(10) PMID: 37906508
- 8. Yakobov N et al.. 2020. RNA-dependent sterol aspartylation in fungi.. Proc Natl Acad Sci U S A 117(26):14948-14957 PMID: 32541034
